Latest Transformation News

Audeara Ltd reports a 70% jump in Q2 FY25 cash receipts, driven by new product launches and a major contract with Avedis Zildjian. The company’s expansion into Taiwan and international markets signals a promising growth trajectory.

Clever Culture Systems Ltd has achieved a key cashflow break-even milestone in Q4 2024, driven by strong sales growth from major pharmaceutical clients including AstraZeneca and Bristol Myers Squibb. The company is also advancing its product line with a new APAS® Contact Plate capability set for mid-2025 launch.

Castle Minerals Limited reports promising drilling results at its Wa Gold Project and secures a transformative $3 million investment from Ghana's Minerals Income Investment Fund for its Kambale Graphite Project.

Rumble Resources has unveiled a significant resource upgrade at its Western Queen Project alongside a strategic joint venture to fast-track gold production, while advancing metallurgical progress at its Earaheedy zinc project.

Dynamic Metals has reported significant gold anomalies and exceptionally high-grade rock chip results at its Cognac West prospect within the Widgiemooltha Project, advancing plans for drilling in early 2025.

Cyclone Metals has forged a strategic partnership with Vale S.A. to fund and develop its Iron Bear iron ore project in Canada, marking a major step towards mining decision. The company also completed pilot production of high-grade direct reduction pellets, underscoring the project's technical promise.

Sigma Healthcare has achieved unanimous shareholder approval for its proposed merger with Chemist Warehouse, marking a pivotal step toward reshaping Australia's pharmaceutical retail landscape. The merger now awaits final court approval, with implementation anticipated in mid-February 2025.

Sigma Healthcare has successfully passed all key resolutions at its extraordinary general meeting, clearing a major hurdle for its proposed merger with Chemist Warehouse. The deal now awaits final court approval, with implementation expected in February.

Euroz Hartleys Group reports a striking 501% jump in net profit for H1 FY2025, driven by strong capital raising and diversified revenue streams, prompting a dividend increase to 2 cents per share.

Tissue Repair Limited has commenced patient randomisation in its Phase 3 trial of TR987®, targeting chronic venous leg ulcers, aiming to confirm promising earlier results and potentially transform wound healing treatment.

Opyl Limited's Q2 FY25 update reveals robust progress through key partnerships, a new AI Biotech Fund launch, and strengthened financial footing, positioning the company for expanded influence in clinical trial optimisation.

Lord Resources has secured an earn-in agreement for the Ilgarari Copper Project in Western Australia and commenced detailed gravity surveys, marking a significant step in its copper exploration strategy.